Scalp Cooling System Reduces Cancer Patients Hair Loss
|
By HospiMedica International staff writers Posted on 02 Jul 2019 |
|
Image: The fourth-generation DigniCap Delta scalp cooling system (Photo courtesy of Dignitana).
A fourth-generation medical cooling device offers cancer patients the ability to minimize alopecia (hair loss) during chemotherapy treatments.
The Dignitana (Lund, Sweden) DigniCap Delta scalp cooling system is indicated for the prevention of chemotherapy-induced hair loss in patients with solid tumors. The system works by circulating liquid coolant through a flexible cooling wrap and an adjustable thermal cap that optimize scalp cooling outcomes. The cooling wrap is placed directly on the head to deliver consistent, controlled cooling to the scalp, while the outer thermal neoprene cap insulates and secures it tightly in place, with two built-in sensors continuously monitoring scalp temperature in order to maintain optimal cooling throughout.
Key system features include a quick-disconnect to accommodate bathroom breaks, an intuitive touch screen interface to simplify system operation, and flash memory that makes it possible to save data from each scalp cooling treatment and facilitates software upgrades. A built-in safety sensor ensures cooling temperature does not drop below freezing point. The cooling cap itself is available in multiple sizes to insure a personalized fit, and has a smooth inner surface to enable optimal contact between scalp and cap. Two independently controlled systems can be used for simultaneous treatment of two patients.
“DigniCap Delta changes everything about the way scalp cooling is done today. We are thrilled to offer patients and clinicians this state-of-the-art advancement in cancer care,” said William Cronin, CEO of Dignitana. “The clearance of Delta now provides a clear pathway for growth in the important US market and beyond. It is the biggest step yet in the evolution of Dignitana, and is the result of a tremendous effort from our staff, partner sites, regulatory team and contract manufacturer.”
As the temperature of the scalp is lowered, the subsequent blood vessel vasoconstriction reduces the amount of chemotherapy agents that reach it, as well as reducing uptake of drugs in the hair follicles due to decreased intra-follicular metabolic rate. The combined actions are thought to reduce the effect chemotherapy has on the cells, which may reduce hair loss.
Related Links:
Dignitana
The Dignitana (Lund, Sweden) DigniCap Delta scalp cooling system is indicated for the prevention of chemotherapy-induced hair loss in patients with solid tumors. The system works by circulating liquid coolant through a flexible cooling wrap and an adjustable thermal cap that optimize scalp cooling outcomes. The cooling wrap is placed directly on the head to deliver consistent, controlled cooling to the scalp, while the outer thermal neoprene cap insulates and secures it tightly in place, with two built-in sensors continuously monitoring scalp temperature in order to maintain optimal cooling throughout.
Key system features include a quick-disconnect to accommodate bathroom breaks, an intuitive touch screen interface to simplify system operation, and flash memory that makes it possible to save data from each scalp cooling treatment and facilitates software upgrades. A built-in safety sensor ensures cooling temperature does not drop below freezing point. The cooling cap itself is available in multiple sizes to insure a personalized fit, and has a smooth inner surface to enable optimal contact between scalp and cap. Two independently controlled systems can be used for simultaneous treatment of two patients.
“DigniCap Delta changes everything about the way scalp cooling is done today. We are thrilled to offer patients and clinicians this state-of-the-art advancement in cancer care,” said William Cronin, CEO of Dignitana. “The clearance of Delta now provides a clear pathway for growth in the important US market and beyond. It is the biggest step yet in the evolution of Dignitana, and is the result of a tremendous effort from our staff, partner sites, regulatory team and contract manufacturer.”
As the temperature of the scalp is lowered, the subsequent blood vessel vasoconstriction reduces the amount of chemotherapy agents that reach it, as well as reducing uptake of drugs in the hair follicles due to decreased intra-follicular metabolic rate. The combined actions are thought to reduce the effect chemotherapy has on the cells, which may reduce hair loss.
Related Links:
Dignitana
Gold Member
12-Channel ECG
CM1200B
New
X-Ray Generator
Advantage Plus Generators
New
Medical-Grade Display
HL2316SHTB
Latest Critical Care News
- Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
- Eye Imaging AI Identifies Elevated Cardiovascular Risk
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Surgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
